Recently, Baolingbao stated that the domestic use of allulose is still under review and the approval time is uncertain. The company uses synthetic biology, enzyme engineering and fermentation engineering technologies to biosynthesize human milk oligosaccharides, and studies related strains of new sugar source products such as erythritol and allulose to improve product conversion rate and energy utilization, and strive to enhance the company's cost advantage.

For specific market inquiries, please contact: davi@vegapharma.com